Iovance Biotherapeutics Inc
(IOVA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 228,752 | 134,188 | 114,888 | 267,720 | 230,010 |
| Marketable Securities | 183,864 | 222,007 | 164,979 | 93,654 | 20,884 |
| Receivables | 31,604 | 234 | 151 | N/A | 33 |
| Inventories | 27,854 | 17,617 | 10,372 | 9,195 | 9,720 |
| TOTAL | $482,257 | $385,533 | $307,848 | $382,586 | $274,878 |
| Non-Current Assets | |||||
| PPE Net | 110,960 | 111,789 | 114,030 | 113,142 | 112,549 |
| Intangibles | 295,299 | 294,303 | 229,258 | 223,610 | 235,511 |
| Other Non-Current Assets | 75,806 | 78,205 | 129,215 | 132,977 | 134,355 |
| TOTAL | $482,065 | $484,297 | $472,503 | $469,729 | $482,415 |
| Total Assets | $964,322 | $869,830 | $780,351 | $852,315 | $757,293 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,416 | 25,700 | 33,123 | 19,274 | 31,157 |
| Accrued Expenses | 61,787 | 46,436 | 69,406 | 61,213 | 46,620 |
| TOTAL | $93,639 | $83,214 | $110,306 | $90,955 | $88,643 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Other Non-Current Liabilities | 69,246 | 72,291 | 67,085 | 68,009 | 68,844 |
| TOTAL | $102,143 | $106,592 | $85,432 | $87,352 | $90,081 |
| Total Liabilities | $195,782 | $189,806 | $195,738 | $178,307 | $178,724 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 303,514 | 279,833 | 279,307 | 255,918 | 247,777 |
| Common Shares | 12 | 12 | 11 | 11 | 9 |
| Retained earnings | -2,222,452 | -2,125,351 | -2,012,375 | -1,895,996 | -1,782,236 |
| Other shareholders' equity | 526 | 116 | 2,526 | -9,097 | 325 |
| TOTAL | $768,540 | $680,024 | $584,613 | $674,008 | $578,569 |
| Total Liabilities And Equity | $964,322 | $869,830 | $780,351 | $852,315 | $757,293 |